Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.

National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...

The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...

Navigating compliance challenges and technology solutions under DSCSA.